Literature DB >> 2801679

A new technique for segmental jejunal perfusion in man.

L Knutson1, B Odlind, R Hällgren.   

Abstract

A multichannel tube with two occluding balloons was developed for measurements of the secretion of different endogenous substances into a defined segment of the small intestine. The tube was inserted under fluoroscopic guidance with the aid of a guide wire and was in position in the proximal jejunum after 45-90 min. The overall success rate of the complete procedure was 90%. The system prevented contamination of the perfusate from gastric and pancreatic secretion. Major dilution of the intestinal secretion was avoided due to high recovery of the perfusion fluid. The jejunal secretion rates of high and low molecular weight substances, i.e., albumin, beta 2-microglobulin, hyaluronan, and histamine, were tested. The recovery of the effluent fluid and the volume marker 14C-PEG 4000 exceeded 95% and was also stable over the perfusion period. The mean secretion rates in 23 healthy controls of albumin (635 micrograms/cm/h), beta 2-microglobulin (0.87 microgram/cm/h), hyaluronan (1061 ng/cm/h), and histamine (70 ng/cm/h) were also stable during the perfusion period. Ten healthy controls were studied under steady state conditions for 3 h. The concentrations in jejunal perfusion fluid relative to serum levels were for albumin 0.06%, indicating the degree of passive leakage from the plasma compartment to the intestinal lumen. The appearance of the low-molecular weight protein beta 2-microglobulin in perfusion fluid was on average 3% of its circulating levels, suggesting that the concentrative transport from plasma is dependent on the molecular size. The jejunal fluid concentrations of histamine and hyaluronan exceeded their respective concentrations in plasma, indicating that local intestinal secretion/synthesis is mainly responsible for their appearance in jejunal fluid. In summary, the technique is simple, rapid, atraumatic, safe, and reproducible and, potentially, can accurately reflect biochemical processes in the small intestine.

Entities:  

Mesh:

Year:  1989        PMID: 2801679

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  26 in total

1.  Biopharmaceutical characterisation of herbal medicinal products: are in vivo studies necessary?

Authors:  H H Blume; B S Schug
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Jan-Mar       Impact factor: 2.441

2.  Class and subclass-associated specificity differences of anti-gliadin antibodies from mucosa and serum.

Authors:  P E Engström; U Sundin; B Lavö; G Norhagen; R Hällgren; C I Smith; L Hammarström
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

3.  Cell recovery during segmental intestinal perfusion in healthy subjects and patients with Crohn's disease.

Authors:  O Ahrenstedt; F Knutson; L Knutson; M Krog; O Sjöberg; R Hällgren
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

4.  Jejunal secretion of secretory immunoglobulins and gliadin antibodies in celiac disease.

Authors:  B Lavö; F Knutson; L Knutson; O Sjöberg; R Hällgren
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

5.  Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  O Mäki-Ikola; R Hällgren; L Kanerud; N Feltelius; L Knutsson; K Granfors
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

6.  Characterization of fluids from the stomach and proximal jejunum in men and women.

Authors:  A Lindahl; A L Ungell; L Knutson; H Lennernäs
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

7.  The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum.

Authors:  D Nilsson; U Fagerholm; H Lennernäs
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

8.  Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy.

Authors:  Ian R Wilding; Alyson L Connor; Polly Carpenter; Christiane Rordorf; Janice Branson; Slavica Milosavljev; Graham Scott
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

9.  Failure of tropisetron to inhibit jejunal water and electrolyte secretion induced by 5-hydroxytryptamine in healthy volunteers.

Authors:  L K Munck; O Eskerod; M B Hansen; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 10.  Population-based mechanistic prediction of oral drug absorption.

Authors:  Masoud Jamei; David Turner; Jiansong Yang; Sibylle Neuhoff; Sebastian Polak; Amin Rostami-Hodjegan; Geoffrey Tucker
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.